Market cap
$3 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1 Mln
-
ROE
-1.1 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-0.3
-
Debt to Equity
0.8
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
380,648
7 Years Aggregate
CFO
$-15.64 Mln
EBITDA
$-12.50 Mln
Net Profit
$-22.50 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SeqLL Inc (SQL)
| -3.1 | -20.8 | -76.3 | -68.5 | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
|---|---|---|
|
SeqLL Inc (SQL)
| -64.5 | -84.4 |
|
S&P Small-Cap 600
| 13.9 | -17.4 |
|
BSE Sensex
| 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout SeqLL Inc (SQL)
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing... technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts. Read more
-
Co-Founder, Pres, CEO & Chairman
Mr. Daniel Robert Jones
-
Co-Founder, Pres, CEO & Chairman
Mr. Daniel Robert Jones
-
Headquarters
Billerica, MA
-
Website
FAQs for SeqLL Inc (SQL)
What is the current share price of SeqLL Inc (SQL) Today?
The share price of SeqLL Inc (SQL) is $4.00 (NASDAQ) as of 12-Jan-2024 09:30 EDT. SeqLL Inc (SQL) has given a return of -68.52% in the last 1 years.
What is the current PB & PE ratio of SeqLL Inc (SQL)?
Since, TTM earnings of SeqLL Inc (SQL) is negative, P/E ratio is not available.
The P/B ratio of SeqLL Inc (SQL) is 0.97 times as on 12-Jan-2024, a 75 discount to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
What is the 52 Week High and Low of SeqLL Inc (SQL)?
The 52-week high and low of SeqLL Inc (SQL) are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of SeqLL Inc (SQL)?
SeqLL Inc (SQL) has a market capitalisation of $ 3 Mln as on 12-Jan-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in SeqLL Inc (SQL)?
Before investing in SeqLL Inc (SQL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.